Skip to menu Skip to content Skip to footer
Dr Lauren Aoude
Dr

Lauren Aoude

Email: 
Phone: 
+61 7 344 38027

Overview

Background

Dr Lauren Aoude is a research leader at the University of Queensland (UQ) Frazer Institute. Her research program explores barriers to precision oncology, and establishes more accurate prognostics to enhance therapeutic options for oesophageal adenocarcinoma (OAC) and melanoma patients. Her research integrates genomic sequencing data with clinical, pathological and imaging information. Recent work includes the establishment of patient-derived organoid models to enable a personalised medicine approach.

During her PhD (completed Nov 2014, QIMR Berghofer) she was a key member of international collaborations that significantly enhanced the understanding of melanoma susceptibility in at-risk families. Dr Aoude joined UQ as an NHMRC Early Career Fellow (2016-2021), where she led projects exploring precision medicine for metastatic melanoma and oesophageal cancer. In 2021, she was awarded a UQ Amplify fellowship to pursue research while expanding teaching and mentoring opportunities, including an on-going course co-ordinator role in the Master of Medicine Skin Cancer Program.

In 2025, she was awarded an NHMRC (EL2) Emerging Leader Fellowship. Her program vision is to better inform treatment decisions and improve health outcomes for patients through the integration of genomics into the clinic.

Availability

Dr Lauren Aoude is:
Available for supervision

Qualifications

  • Bachelor of Arts, The University of Queensland
  • Bachelor of Engineering, The University of Queensland
  • Doctor of Philosophy, The University of Queensland

Works

Search Professor Lauren Aoude’s works on UQ eSpace

48 works between 2008 and 2024

41 - 48 of 48 works

2012

Journal Article

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

Dutton-Regester, Ken, Aoude, Lauren G., Nancarrow, Derek J., Stark, Mitchell S., O'Connor, Linda, Lanagan, Cathy, Pupo, Gulietta M., Tembe, Varsha, Carter, Candace D., O'Rourke, Michael, Scolyer, Richard A., Mann, Graham J., Schmidt, Christopher W., Herington, Adrian and Hayward, Nicholas K. (2012). Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene. Genes Chromosomes and Cancer, 51 (5), 452-461. doi: 10.1002/gcc.21932

Identification of TFG (TRK-fused gene) as a putative metastatic melanoma tumor suppressor gene

2012

Journal Article

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

Stark, Mitchell S., Woods, Susan L., Gartside, Michael G., Bonazzi, Vanessa F., Dutton-Regester, Ken, Aoude, Lauren G., Chow, Donald, Sereduk, Chris, Niemi, Natalie M., Tang, Nanyun, Ellis, Jonathan J., Reid, Jeffrey, Zismann, Victoria, Tyagi, Sonika, Muzny, Donna, Newsham, Irene, Wu, YuanQing, Palmer, Jane M., Pollak, Thomas, Youngkin, David, Brooks, Bradford R., Lanagan, Catherine, Schmidt, Christopher W., Kobe, Bostjan, MacKeigan, Jeffrey P., Yin, Hongwei, Brown, Kevin M., Gibbs, Richard, Trent, Jeffrey and Hayward, Nicholas K. (2012). Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing. Nature Genetics, 44 (2), 165-169. doi: 10.1038/ng.1041

Frequent somatic mutations in MAP3K5 and MAP3K9 in metastatic melanoma identified by exome sequencing

2012

Journal Article

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma

Dutton-Regester, Ken, Irwin, Darryl, Hunt, Priscilla, Aoude, Lauren G., Tembe, Varsha, Pupo, Gulietta M., Lanagan, Cathy, Carter, Candace D., O'Connor, Linda, O'Rourke, Michael, Scolyer, Richard A., Mann, Graham J., Schmidt, Christopher W., Herington, Adrian and Hayward, Nicholas K. (2012). A high-throughput panel for identifying clinically relevant mutation profiles in melanoma. Molecular Cancer Therapeutics, 11 (4), 888-897. doi: 10.1158/1535-7163.MCT-11-0676

A high-throughput panel for identifying clinically relevant mutation profiles in melanoma

2011

Journal Article

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

Yokoyama, Satoru, Woods, Susan L., Boyle, Glen M., Aoude, Lauren G., MacGregor, Stuart, Zismann, Victoria, Gartside, Michael, Cust, Anne E., Haq, Rizwan, Harland, Mark, Taylor, John C., Duffy, David L., Holohan, Kelly, Dutton-Regester, Ken, Palmer, Jane M., Bonazzi, Vanessa, Stark, Mitchell S., Symmons, Judith, Law, Matthew H., Schmidt, Christopher, Lanagan, Cathy, O'Connor, Linda, Holland, Elizabeth A., Schmid, Helen, Maskiell, Judith A., Jetann, Jodie, Ferguson, Megan, Jenkins, Mark A., Kefford, Richard F. ... Brown, Kevin M. (2011). A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature, 480 (7375), 99-103. doi: 10.1038/nature10630

A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma

2011

Journal Article

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma

Bonazzi, Vanessa F., Nancarrow, Derek J., Stark, Mitchell S., Moser, Ralf J., Boyle, Glen M., Aoude, Lauren G., Schmidt, Christopher and Hayward, Nicholas K. (2011). Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma. PLoS One, 6 (10) e26121, 1-9. doi: 10.1371/journal.pone.0026121

Cross-platform array screening identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as genes frequently silenced by methylation in melanoma

2011

Journal Article

Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor

Boyle, Glen M., Woods, Susan L., Bonazzi, Vanessa F., Stark, Mitchell S., Hacker, Elke, Aoude, Lauren G., Dutton-Regester, Ken, Cook, Anthony L., Sturm, Richard A. and Hayward, Nicholas K. (2011). Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor. Pigment Cell and Melanoma Research, 24 (3), 525-537. doi: 10.1111/j.1755-148X.2011.00849.x

Melanoma cell invasiveness is regulated by miR-211 suppression of the BRN2 transcription factor

2010

Journal Article

Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers

Whiteman, D.C., Parmar, P., Fahey, P., Moore, S.P., Stark, M., Zhao, Z.Z., Montgomery, G.W., Green, A.C., Hayward, N.K., Webb, P.M., Australian Cancer Study and Aoude, Lauren (2010). Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology, 139 (1), 73-83. doi: 10.1053/j.gastro.2010.04.009

Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers

2008

Conference Publication

Cell culture-based assays identify edible rainforest fruits with potential for chemoprevention of cancer

Aoude, L., Ferguson, B., Gordon, V., Johns, J., Maslovskaya, L., Parsons, P., Pierce, C., Reddell, P., Savchenko, A. and Williams, C. (2008). Cell culture-based assays identify edible rainforest fruits with potential for chemoprevention of cancer. 4th Australian Health and Medical Research Congress, Brisbane, Australia, 16-21 November 2008. Sydney, Australia: AHMRC.

Cell culture-based assays identify edible rainforest fruits with potential for chemoprevention of cancer

Funding

Current funding

  • 2025 - 2029
    Enabling precision medicine for oesophageal cancer patients
    NHMRC Investigator Grants
    Open grant
  • 2023 - 2025
    Radiomics analysis to improve outcomes for melanoma patients (Cancer Australia via the Priority-driven Collaborative Cancer Research Scheme (PdCCRS))
    Cancer Australia
    Open grant
  • 2023 - 2026
    Assessment of tumour phenotype for precision medicine in oesophageal cancer via deep learning analysis of medical images
    CCQ Accelerating Collaborative Cancer Research
    Open grant
  • 2020 - 2025
    Improving outcomes for patients with melanoma brain metastases
    Community Skilling & Disability Support Service Inc (trading name: Civic Solutions)
    Open grant

Past funding

  • 2022 - 2024
    Investigating tumour evolution to improve precision medicine in patients with oesophageal adenocarcinoma (MSH RSS Project Grant led by Metro South Health)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2021
    Cancer Evolution Biobank
    PA Research Foundation
    Open grant
  • 2019 - 2021
    Tumour neo-antigen-specific immune responses in oesophageal cancer long-term survivors: proof-of-concept for improved personalised therapeutic strategies
    Metro South Hospital and Health Service
    Open grant
  • 2018 - 2019
    Genomics and biological correlates of radiomics in melanoma (Cancer Australia administered project funded by Cure Cancer Australia)
    Cure Cancer Australia Foundation
    Open grant
  • 2017 - 2018
    Dr Lauren Aoude - Maternity Funding (Advance Queensland Women's Academic Fund)
    Queensland Government Advance Queensland Women's Academic Fund
    Open grant
  • 2016 - 2021
    Feasibility of implementing precision medicine for the treatment of metastatic melanoma
    NHMRC Early Career Fellowships
    Open grant

Supervision

Availability

Dr Lauren Aoude is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

Media

Enquiries

For media enquiries about Dr Lauren Aoude's areas of expertise, story ideas and help finding experts, contact our Media team:

communications@uq.edu.au